Does new onset and pre-existing atrial fibrillation predict mortality in COVID-19 patients?

Does new onset and pre-existing atrial fibrillation predict mortality in COVID-19 patients?

Abstract Background Coronavirus Disease-2019 (COVID-19), caused by Severe Acute Respiratory Syndrome-Coronavirus-2, still remains prevalent and severe. We aimed to evaluate the effects of pre-existing atrial fibrillation and new-onset atrial fibrillation (NOAF) on the clinical severity and mortality...

Full description

Bibliographic Details
Main Authors: Selim Aydemir, Emrah Aksakal, Faruk Aydınyılmaz, Oktay Gülcü, İbrahim Saraç, Sidar Şiyar Aydın, Remziye Doğan, Merve Lazoğlu, Kamuran Kalkan
Format: Article
Language:English
Published: SpringerOpen 2022-07-01
Series:The Egyptian Heart Journal
Subjects:
COVID-19
Atrial fibrillation
Mortality
Online Access:https://doi.org/10.1186/s43044-022-00291-9

Internet

https://doi.org/10.1186/s43044-022-00291-9

Similar Items